Loading
Loading
Review of Case Materials
Reviews records, documents, testimony, data, and other relevant materials and consults with counsel regarding technical issues related to the matter.
Provide Expert Analysis
Applies specialized knowledge and experience to evaluate the technical or professional issues involved.
Form Expert Opinions
Develops independent, supportable opinions based on the available evidence and relevant standards.
Prepare Expert Reports
Showing Results 0 of 0
The meaning should be tied to the specific substance and legal context rather than assumed from the term alone. Under the federal Controlled Substances Act, the statutory definition of “narcotic drug” includes opium and opiates and certain derivatives, as well as poppy straw, coca leaves, cocaine, ecgonine, and qualifying preparations containing those substances. DEA educational materials also use “narcotics” in an opioid context, describe “opioid” as a more current term, and distinguish natural, semi-synthetic, and synthetic opioids. A suitably qualified narcotics expert witness can identify the substance involved and explain the scientific terminology relevant to the evidence without treating all controlled substances, or the statutory and scientific uses of “narcotic,” as technically interchangeable.
Relevant questions may include which type of specimen was collected, how it was handled, what initial and confirmatory testing procedures were used, what drug or metabolite was identified, and how the reported result should be interpreted. Depending on the issue, toxicological analysis may also involve laboratory quality-control information, analytical limitations, applicable reporting thresholds, and the timing between alleged exposure and specimen collection. A laboratory result should be interpreted within its evidentiary context. SAMHSA, for example, cautions in the federal workplace-testing context that a laboratory-confirmed positive result does not automatically establish that a person misused drugs.
Pharmacology can become important when the dispute concerns how a drug is absorbed, distributed, metabolized, eliminated, produces effects, or interacts with another drug. Prescription records, dose and timing information, known metabolites, potential drug interactions, and pharmacokinetic or pharmacodynamic evidence may therefore require examination. When those questions become the principal issue rather than supporting evidence about the narcotic itself, a suitably qualified pharmacology expert witness may be more appropriate. FDA clinical pharmacology materials address pharmacokinetics, pharmacodynamics, and drug interactions as areas relevant to understanding drug exposure, effects, and interactions.
Prepares clear, well-supported expert reports outlining methodology, analysis, findings, and opinions.
Provide Deposition Testimony
Explains findings and opinions under oath and responds to questioning during deposition testimony.
Testify in Court
Presents specialized findings and opinions clearly to judges, juries, arbitrators, or other decision-makers.
Evidence of repeated narcotic use does not by itself establish that a person meets the diagnostic criteria for a substance use disorder. Clinical evaluation considers a defined set of diagnostic criteria, and medical history, prescribing records, treatment records, and related clinical evidence may be relevant when a substance use disorder is actually disputed. A suitably qualified narcotics expert witness can address drug-related evidence within the expert's qualifications, while diagnosis, treatment, or specialized addiction-medicine opinions may require separate addiction-medicine or other appropriately qualified clinical expertise.
